Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-28.04%
↑ 99% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-3970.39%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -28.04% | +94.1% |
| 2024 | -473.33% | +98.0% |
| 2023 | -23320.97% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |